NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has signed a supply and distribution agreement enabling it to offer its customers access to Sirion Biotech's RNAiONE custom short hairpin RNA development services.
A study published in Nature Genetics last month has identified a genetic variant strongly associated with higher risk of certain brain tumors, and suggests the involvement of a long non-coding RNA or a microRNA.
Alnylam Pharmaceuticals this week announced that it has taken a non-exclusive license to RNAi-related intellectual property held by UK technology management firm Plant Bioscience Limited.
